Dexlevo
Latest round
- Series B
Last raised
- Aug 2018
Total raised
- $4.9M
Investors
- 2
About Dexlevo
Dexlevo, founded in 2013 and headquartered in Seoul, South Korea, focuses on medical aesthetics.DEXLEVO INC. specializes in the research and manufacturing of medical aesthetic products, primarily focusing on advanced polymer technology. Their core offerings include the Collagenesis-Enabled Solubilized Active Biodegradable Polymer Smart Drug Delivery System, which innovatively addresses unmet needs in the aesthetic market by providing effective delivery mechanisms for active ingredients. This product targets both medical professionals and end users seeking advanced aesthetic treatments, ensuring optimal results through a smart delivery system that enhances the efficacy of pharmaceuticals.Revenue generation for DEXLEVO INC. is predominantly structured around B2B transactions, where they collaborate directly with healthcare providers and aesthetic clinics. In 2018, the company reported a revenue of KRW 610,488 and an EBITDA of KRW -482,218. The company aims to launch new products in the upcoming years, targeting specific markets for expansion, particularly in North America and Europe, by 2023.
Who invested in Dexlevo
2 investors across 1 round
See all investors in Dexlevo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 24, 2018
Amount
$4.9M
Investors
Questions about Dexlevo
Who invested in Dexlevo?
Dexlevo has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dexlevo raised?
Dexlevo has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dexlevo last raise money?
Dexlevo's most recent round on record is a Series B, in Aug 2018.
What does Dexlevo do?
Dexlevo, founded in 2013 and headquartered in Seoul, South Korea, focuses on medical aesthetics.
Where is Dexlevo headquartered?
Dexlevo is headquartered in Seoul, South Korea.
Which VCs invest in companies like Dexlevo?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at Dexlevo's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Dexlevo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.